Nirali Shah

90PUBLICATIONS
365CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematologyChild and adolescent development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (90)

|Aug 11, 2026
Predictive Models for Toxicities after CAR T-cell Therapy: Challenges and Opportunities.

|Jul 16, 2026
Enabling access to talicabtagene autoleucel in relapsed/refractory B-cell malignancies; multicenter real-world evidence on delivery, efficacy and safety.

|Jun 26, 2026
Plasticity under pressure: biology and detection of lineage switch in acute leukemia.

|Jun 05, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results.

|May 12, 2026
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.

|Mar 04, 2026
How I treat HLH-like toxicities after immune effector cell therapy.

William T Johnson, Kevin O McNerney, Matthew J Frank

Pageof 15

Frequent Collaborators

14 joint publications

Constance Yuan

10 joint publications

Terry J Fry

9 joint publications

Daniel W Lee

8 joint publications

Hao-Wei Wang